XML 43 R17.htm IDEA: XBRL DOCUMENT v3.24.4
PREPAID EXPENSES AND OTHER CURRENT ASSETS
 9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
PREPAID EXPENSES AND OTHER CURRENT ASSETS PREPAID EXPENSES AND OTHER CURRENT ASSETS
Prepaid expenses and other current assets at September 30, 2024 and December 31, 2023 consisted of the following:
September 30, 2024December 31, 2023
Insurance$419,602 $468,495 
Other prepaid and current assets119,015 151,268 
Total prepaid expenses and other current assets$538,617 $619,763 
Insurance is mainly comprised of prepaid directors’ and officers’ insurance. In July 2024, the Company financed its directors and officers’ insurance premium with a short term note, the principal amount of which is approximately $0.4 million bearing interest at a rate of 9.74%. The note payable balance, which was included within Current Liabilities on the Condensed Consolidated Balance Sheet was $0.3 million at both September 30, 2024 and December 31, 2023. 		PREPAID EXPENSES AND OTHER CURRENT ASSETS
Prepaid expenses and other current assets at December 31, 2023 and 2022 consisted of the following:
December 31,
20232022
Prepaid clinical trial expenses$— $11,185 
Prepaid insurance468,495 624,612 
Other prepaid and current assets151,268 167,576 
Total prepaid expenses and other current assets$619,763 $803,373 
Prepaid insurance is mainly comprised of prepaid directors’ and officers’ insurance. In July 2023, the Company financed its directors and officers’ insurance premium with a short term note the principal amount of which is approximately $0.6 million bearing interest at a rate of 7.87%. The note payable balance, which was included within Current Liabilities on the Consolidated Balance Sheet was $ 0.3 million as of December 31, 2023.